Veradermics, Incorporated
NYSE: MANE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Reid Waldman
- Employees
- 21
- Headquarters
- New Haven, United States
- IPO year
- 2026
- Market cap
- $4.9B
- Website
- https://www.veradermics.com
Loading MANE…
Loading profile data…Frequently asked questions about MANE
What does Veradermics, Incorporated (MANE) do?
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally admi...
Where does MANE trade?
Veradermics, Incorporated (MANE) trades on the New York Stock Exchange.
What sector is MANE in?
Veradermics, Incorporated (MANE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Veradermics, Incorporated?
Reid Waldman is the chief executive officer of Veradermics, Incorporated (MANE).
Where is Veradermics, Incorporated headquartered?
Veradermics, Incorporated is headquartered in United States.
Does MANE pay a dividend?
Veradermics, Incorporated (MANE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MANE go public?
Veradermics, Incorporated (MANE) completed its initial public offering in 2026.